Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-19
1997-02-11
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5462687, A61K 3144
Patent
active
056021542
ABSTRACT:
2-(2,3,5,6-Tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides, pharmaceutical compositions containing them and methods for the treatment of degenerative diseases utilizing them.
REFERENCES:
patent: 5236917 (1993-08-01), Dunlap et al.
Huffer et al. Introduction to Human Immunology, pp. 157-161, Jones and Bartlett Publishers, Inc. 1986.
Cha, Biochem. Pharmacol., 1975, 24, 2177-2185.
Groutas et al., Biochemical and Biophysical Research Communications 1994, 198(1), 341-349.
Muller and DuBois, J. Org. Chem. 1989, 54, 4471-4473.
Lee et al., J. Org. Chem. 1989, 54, 3077-3083.
Lee and Kohn, Journal of Pharmaceutical Sciences 1990, 79(8), 716-718.
Hanewacker et al., Arch. Pharm. 1993, 326, 497-498.
Unterhalt and Hanewacker, Arch. Pharm. 1988, 321, 375-376.
Unterhalt and Hanewacker, Arch. Pharm. 1988, 321, 749-751.
Aouf et al., Tetrahedron Letters 1991, 32(45), 6545-6546.
Dewynter et al., Tetrahedron 1993, 49(1), 65-76.
Davis William J.
DuPont Paul E.
Fan Jane
Sanofi Winthrop Inc.
LandOfFree
2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342482